Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF OPERATIONS

v3.24.0.1
STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
OPERATING EXPENSES    
Research and Development $ 6,043,597 $ 4,754,271
General and Administrative 8,534,171 7,338,505
TOTAL OPERATING EXPENSES 14,577,768 12,092,776
NET LOSS $ (14,577,768) $ (12,092,776)
LOSS PER SHARE    
Basic net loss per common share $ (1.15) $ (1.12)
Diluted net loss per common share $ (1.15) $ (1.12)
Weighted average common shares outstanding basic 12,671,572 10,816,412
Weighted average common shares outstanding diluted 12,671,572 10,816,412